New hope for tough breast cancer: drug cocktail targets resistant tumors
NCT ID NCT02593175
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase II trial tested a combination of panitumumab (a targeted therapy) plus two chemotherapy drugs (carboplatin and paclitaxel) given before surgery to women with triple-negative breast cancer that didn't respond to standard chemo. The goal was to shrink tumors and reduce the amount of tissue needing removal. The study enrolled 43 participants with early-stage breast cancer and measured how many had no cancer left at surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- panitumumab, carboplatin, and paclitaxel
- What this could lead to
- If successful, this combination could shrink tumors before surgery, potentially improving outcomes for people with triple-negative breast cancer that doesn't respond to standard chemotherapy.
- What could go wrong
- This is a small, early-phase trial with only 43 participants, so results may not apply to everyone. The drugs can cause side effects like low blood counts, nerve damage, and skin reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE I BREAST CANCER AJCC V7 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a triple drug combo shrink HER2-Positive breast tumors before surgery?
- Digital therapy aims to tame the fear that haunts cancer survivors
- Can a vaccine train the immune system to hunt down hidden breast cancer cells?
- Gene test could guide breast cancer treatment to boost survival
- Could a gentler chemo work for older breast cancer patients?
- Vaccine aims to block return of aggressive breast cancer